Back Pain and the Mineralocorticoid Receptor
Open Access
- 1 November 2012
- journal article
- editorial
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 117 (5) , 951-952
Abstract
“What accounts for such divergent and often lackluster outcomes in the use of glucocorticoids in the treatment of back pain?…Perhaps there are additional spinal-ganglionic steroid-receptor pathways that confound the resolution of injury-induced neuroinflammation and pain.”Keywords
This publication has 9 references indexed in Scilit:
- Mineralocorticoid Receptor Blocker Eplerenone Reduces Pain Behaviors In Vivo and Decreases Excitability in Small-diameter Sensory Neurons from Local Inflamed Dorsal Root Ganglia In VitroAnesthesiology, 2012
- The respective and interaction effects of spinal GRs and MRs on radicular pain induced by chronic compression of the dorsal root ganglion in the ratBrain Research, 2011
- Transient Receptor Potential Channels in Pain and Inflammation: Therapeutic OpportunitiesPain Practice, 2010
- Corticosteroid receptors, macrophages and cardiovascular diseaseJournal of Molecular Endocrinology, 2009
- Robust increase of cutaneous sensitivity, cytokine production and sympathetic sprouting in rats with localized inflammatory irritation of the spinal gangliaNeuroscience, 2006
- Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosteroneProceedings of the National Academy of Sciences, 2005
- Differences in the determinants of eplerenone, spironolactone and aldosterone binding to the mineralocorticoid receptor*Clinical and Experimental Pharmacology and Physiology, 2004
- ALDOSTERONEAdvances in Physiology Education, 2002
- Mineralocorticoid Action: Target Tissue Specificity Is Enzyme, Not Receptor, MediatedScience, 1988